Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise? Reply

SM Greenberg, RAS Salman, GJ Biessels, M van Buchem, C Cordonnier, JM Lee, J Montaner, JA Schneider, EE Smith, Meike Vernooij, DJ Werring

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)540-540
Number of pages1
JournalLancet Neurology
Volume13
Issue number6
Publication statusPublished - 2014

Cite this